Cargando…
Astaxanthin improves fatty acid dysregulation in diabetes by controlling the AMPK-SIRT1 pathway
Due to the rising prevalence of metabolic disorders, including type 2 diabetes (T2DM), new prevention and treatment strategies are needed. The aim was to examine the effect of astaxanthin (AST) on the major regulatory metabolism pathway SIRT-MAPK and fatty acid (FA) profile of plasma in patients wit...
Autores principales: | Taghiyar, Sana, Pourrajab, Fatemeh, Aarabi, Mohammad Hosein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391612/ https://www.ncbi.nlm.nih.gov/pubmed/37534224 http://dx.doi.org/10.17179/excli2023-6132 |
Ejemplares similares
-
Antioxidant effects of astaxanthin and metformin combined therapy in type 2 diabetes mellitus patients: a randomized double-blind controlled clinical trial
por: Rad, Nikoo Roustaei, et al.
Publicado: (2022) -
Omega-3 Polyunsaturated Fatty Acids Antagonize Macrophage Inflammation via Activation of AMPK/SIRT1 Pathway
por: Xue, Bingzhong, et al.
Publicado: (2012) -
Ginger Extract Increases GLUT-4 Expression Preferentially Through AMPK Than PI3K Signalling Pathways in C2C12 Muscle Cells
por: Tajik Kord, Marjan, et al.
Publicado: (2020) -
Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022) -
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)